Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Celon Pharma SA (8RP) Stock Price & Analysis

2 Followers

8RP Stock Chart & Stats

€3.53-€0.01(-0.28%)
At close: 5:30 PM GMT+1
€4.5€4.75€5€5.25Jun 29Jul 13Jul 29Aug 3Aug 26Sep 1Sep 24
Day’s Range
EUR 3.53 - EUR 3.53
52-Week Range
EUR 3.53 - EUR 5.77
Previous Close
EUR 3.54
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 199.17M
Enterprise Value
EUR 1.07B
Total Cash (Recent Filing)
EUR 34.53M
Total Debt (Recent Filing)
EUR 128.44M
Price to Earnings (P/E)
7.8
Beta
0.32
Next Earnings
Nov 18, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Gross Profit Margin

A strong gross profit margin indicates effective cost management and pricing power, which can support long-term profitability as the company scales.

Low Leverage

Low leverage provides financial flexibility and reduces risk, allowing the company to invest in growth opportunities without significant debt burden.

Revenue Growth Potential

High revenue growth potential indicates strong demand for products and successful market penetration, supporting long-term business expansion.

Bears Say

Negative Revenue Growth

Negative revenue growth suggests challenges in maintaining sales momentum, which can hinder long-term business sustainability and market competitiveness.

Profitability Challenges

Ongoing profitability challenges indicate operational inefficiencies and may limit the company's ability to reinvest in growth and innovation.

Cash Flow Management Issues

Poor cash flow management can strain financial resources, limiting the company's ability to fund operations and strategic initiatives over the long term.

Celon Pharma SA News

8RP FAQ

What was Celon Pharma SA’s price range in the past 12 months?
Celon Pharma SA lowest stock price was €3.53 and its highest was €5.77 in the past 12 months.
What is Celon Pharma SA’s market cap?
Celon Pharma SA’s market cap is €199.17M.
When is Celon Pharma SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Celon Pharma SA’s earnings last quarter?
Celon Pharma SA released its earnings results on Sep 16, 2026. The company reported -€0.129 earnings per share for the quarter.
Is Celon Pharma SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Celon Pharma SA pay dividends?
Celon Pharma SA does not currently pay dividends.
What is Celon Pharma SA’s EPS estimate?
Celon Pharma SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celon Pharma SA have?
Celon Pharma SA has 53,911,500 shares outstanding.
What happened to Celon Pharma SA’s price movement after its last earnings report?
Celon Pharma SA reported an EPS of -€0.129 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Celon Pharma SA?
Currently, no hedge funds are holding shares in DE:8RP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology